Before revision: A July 2021 study used this predictive marker to validate higher levels of neutralizing antibodies corresponding with lower likelihood of breakthrough infection in COVID-19 .
After revision: A July 2021 study used this predictive marker to validate higher levels of neutralizing antibodies corresponding with lower likelihood of breakthrough infection in COVID-19